Pros and cons of peg-interferon versus nucleos(t)ide analogues for treatment of chronic hepatitis B

Milan Sonneveld, HLA Janssen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)91-98
Number of pages8
JournalCurrent Hepatitis Reports
Volume9
Publication statusPublished - 2010

Cite this